Print Friendly, PDF & Email

HealthTech Review February, 14 2012

GE Healthcare Empowers Patients with Advanced Online Patient Portal

In response to customer demand for a better way to interact with patients in an increasingly self-service climate, GE Healthcare introduced Centricity Patient Online 13. Centricity Patient Online is a flexible, scalable, and highly configurable patient portal designed for large healthcare organizations. By extending the provider workflow to the patient’s home with a range of easy-to-use self-service tools, Patient Online enhances patient communications, optimizes staff and provider productivity, and can help strengthen the provider’s market and competitive position. It helps customers meet Meaningful Use Stage 1 patient and family engagement criteria and prepare them for expected Stage 2 requirements.

Read more…  
 

GE Healthcare Introduces in Mexico, Vscan, the Pocket-Sized Ultrasound Visualization Tool

GE Healthcare introduced in Mexico the pocket-sized, portable visualization tool, Vscan*, a device that enables physicians to quickly look inside the body at the point of care. Vscan’s pocket-friendly size provides clinicians with an immediate, non-invasive method to help obtain visual information about what is happening inside the body. Vscan is portable and can easily be used in hospital, clinics or primary care settings.
This pocket-sized ultrasound device helps redefine the patient examination. Vscan can be a useful tool for healthcare providers in Mexico in several clinical areas.

Read more… 
 

GE Healthymagination Fund Invests in Check-Cap Ltd., Developer of Ingestible Imaging Capsule that could Detect Colorectal Cancer

GE Capital and GE Healthcare, the financial services and healthcare divisions of General Electric Company (NYSE: GE), announced an investment in Check-Cap, Ltd., a developer of an ingestible imaging capsule that may help detect colorectal cancer. The investment is being made through the GE healthymagination Fund, an equity fund that makes investments in highly promising healthcare technology companies.

Check-Cap’s ingestible and disposable imaging capsule is planned to have the capability to image the colon in 3D. The capsule will require no bowel cleansing before ingestion and no hospital visit, allowing patients to go about their daily routines without having to alter their activities.  “Check-Cap’s technology is not only innovative but it presents great promise to change the standard of patient care and to help them avoid the discomfort of traditional colonoscopies,” said GE Vice President & GE Healthcare Chief Technology Officer Mike Harsh.

Read more…
 

Capital Health Will Be First in U.S. to Offer GE Molecular Breast Imaging

Capital Health and GE Healthcare announced the first Discovery* NM 750b was installed at Capital Health’s New Jersey Hopewell medical center. Capital Health is a central New Jersey region leader in advanced medicine, with significant investments in advanced technologies and its medical staff.
GE Healthcare’s Discovery NM 750b is a specialized breast scanner that enables advanced functional imaging of breast cancer.

Read more…
 

GE Healthcare Cardiac CT Scanner Receives NICE Diagnostic Assessment Programme’s First Ever Positive Recommendation

GE Healthcare’s Discovery CT750 HD, the world’s first high-definition CT system, has been included in the first fully positive recommendation from the National Institute for Health and Clinical Excellence (NICE)’s Diagnostic Assessment Programme which aims to ensure the National Health Service (NHS) can rapidly and consistently adopt clinically and cost effective technologies.

Read more…
 

New [18F]Flutemetamol Data Presented at 6th Annual Human Amyloid Imaging Conference

Data presented at the 6th Annual Human Amyloid Imaging (HAI) meeting in Miami suggest that the investigational imaging agent [18F] Flutemetamol could add value to current diagnostic tools used by physicians to evaluate neurodegenerative conditions like Alzheimer’s Disease (AD). [18F]Flutemetamol is a GE Healthcare PET imaging agent in phase III development for the detection of beta amyloid.

Read more…
 

GE, Microsoft Share Plans for New Joint Venture, Caradigm

General Electric Co. (GE), through its healthcare IT business, and Microsoft Corp. announced several developments for their planned 50-50 joint venture, including the intention to demonstrate future product capabilities at HIMSS12, the year’s largest healthcare IT trade show, later this month. The new company, to be named Caradigm™, is expected to launch in the first half of 2012, pending customary closing conditions.

Read more…